Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Orexigen 1Q Loss Narrows

May 9, 2011 9:57 am | News | Comments

Orexigen Therapeutics Inc. reported a narrower first-quarter loss and said it is preparing to discuss its experimental obesity drug Contrave with U.S. regulators.


Pfizer Aims to Expand Prevnar Market

May 9, 2011 9:55 am | by Linda A. Johnson | News | Comments

Two key late-stage studies of Pfizer's blockbuster pneumococcal vaccine for children show it works at least as well as a rival in adults, a big market the drugmaker wants to tap.


A Novel Approach for the Treatment of Atrial Fibrillation

May 9, 2011 9:11 am | News | Comments

Atrial fibrillation is the most common cardiac arrhythmia facing physicians, with recent epidemiological studies estimating that there are over 11 million AF sufferers in the seven major economies.


Managed Content Delivery

May 9, 2011 9:09 am | Product Releases | Comments

IDBS offers ScienceLink, a scientific content brokerage platform that delivers licensed data, provides on-demand scientific content from third parties, and extends how scientists use this information in their research tools.


Biologics/Biosimilar Market Intelligence

May 9, 2011 9:05 am | Drug Discovery & Development | Product Releases | Comments

Thomson Reuters has launched the Newport Biologics Module, a source of competitive intelligence for biologic and biosimilar drugs.


Write on Target

May 9, 2011 9:03 am | by Rita C. Peters, Editorial Director | Articles | Comments

At a time when many publications are cutting back, Drug Discovery & Development is proud to introduce a special supplement, the 2011 CRO/CMO Directory, the definitive guide to outsourcing services, designed as a handy desk reference to service providers in this growing segment of the drug market.

Moffitt Cancer Center Adopts Oracle Informatics Tools

May 9, 2011 9:01 am | Drug Discovery & Development | Product Releases | Comments

Moffitt Cancer Center selected Oracle Health Sciences solutions for its health and research informatics platform.


Clearing a Path for Patents

May 9, 2011 8:56 am | by Ted Agres, Contributing Editor | Articles | Comments

After more than half a dozen years of wrangling, Congress is moving closer to approving the first major update to the U.S. patent system in nearly six decades.


NUVIGIL Shows Efficacy in Shift Work Disorder Patients

May 9, 2011 8:54 am | News | Comments

Cephalon, Inc. presented positive results from a Phase 4 trial of nearly 400 people with excessive sleepiness associated with shift work disorder.


NAG Library Guide Delivers White Paper Concept

May 9, 2011 8:52 am | Product Releases | Comments

A white paper from the Numerical Algorithms Group (NAG),  “The Benefits of Using Rigorously Tested Routines from Numerical Libraries” is written to help drug researchers understand how and why to incorporate and use of extensively documented numerical libraries into their application development practices.


Study Expands Bone Biology Knowledge

May 9, 2011 8:50 am | News | Comments

Acceleron Pharma, Inc. announced preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.


Capturing More in Microscopy Images

May 9, 2011 8:49 am | by Mike May, PhD, Contributing Editor | Articles | Comments

Advanced microscopic cameras use sophisticated sensors to capture images. New developments in sensors are bringing more features into view.


Using Bead-Based Multiplexing Immunoassays to Explore Cellular Response to Drugs

May 9, 2011 8:36 am | by Brett Houser, Bio-Plex Product Manager; Bio-Rad Laboratories,Hercules, Calif. | Articles | Comments

Multiplex bead-based immunoassays, such as Luminex xMAP technology, allow the simultaneous measurement of multiple analytes using a library of antibodies coupled to color-coded beads.


Spectroscopic Data System

May 9, 2011 8:30 am | Product Releases | Comments

Symbion Systems, Inc. released the Symbion-DX, Version 2.5, which includes expanded database functionality, instrument control, spectroscopic data processing, and methods development capabilities.


Increasing Immunoassay Specificity with Novel Plate Formats

May 9, 2011 8:30 am | by Thomas Andersen, MSc, Sr. Technical Adviser; Thermo Fisher Scientific, Roskilde, Denmark | Articles | Comments

Immunoassays are based on the ability of an antibody to bind with high specificity to a specific antigen molecule, producing a measurable signal that can be used to determine quantitative information of the antigen concentration.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.